Citations (154)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (31)
Monica L. Fernández-Quintero, Katharina B. Kroell, Lukas J. Grunewald, Anna-Lena M. Fischer, Jakob R. Riccabona & Klaus R. Liedl. (2022) CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies. mAbs 14:1.
Read now
Read now
Desislava Yanakieva, Lukas Pekar, Andreas Evers, Markus Fleischer, Stephan Keller, Dirk Mueller-Pompalla, Lars Toleikis, Harald Kolmar, Stefan Zielonka & Simon Krah. (2022) Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities. mAbs 14:1.
Read now
Read now
Dennis J. Underwood, Jeffrey Bettencourt & Zahra Jawad. (2022) The manufacturing considerations of bispecific antibodies. Expert Opinion on Biological Therapy 22:8, pages 1043-1065.
Read now
Read now
Stefan Warmuth, Tea Gunde, Daniel Snell, Matthias Brock, Christopher Weinert, Alexandre Simonin, Christian Hess, Julia Tietz, Maria Johansson, Fabio Mario Spiga, Robin Heiz, Naomi Flückiger, Sandro Wagen, Julia Zeberer, Dania Diem, Dana Mahler, Belinda Wickihalder, Simone Muntwiler, Bithi Chatterjee, Benjamin Küttner, Bettina Bommer, Yasemin Yaman, Peter Lichtlen & David Urech. (2021) Engineering of a trispecific tumor-targeted immunotherapy incorporating 4-1BB co-stimulation and PD-L1 blockade. OncoImmunology 10:1.
Read now
Read now
Marlena Surowka, Wolfgang Schaefer & Christian Klein. (2021) Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins. mAbs 13:1.
Read now
Read now
Shion A. Lim, Josef A. Gramespacher, Katarina Pance, Nicholas J. Rettko, Paige Solomon, Jing Jin, Irene Lui, Susanna K. Elledge, Jia Liu, Colton J. Bracken, Graham Simmons, Xin X. Zhou, Kevin K. Leung & James A. Wells. (2021) Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2. mAbs 13:1.
Read now
Read now
Kathryn H. Ching, Kimberley Berg, Kevin Reynolds, Darlene Pedersen, Alba Macias, Yasmina N. Abdiche, William D. Harriman & Philip A. Leighton. (2021) Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics. mAbs 13:1.
Read now
Read now
Romain Ollier, Paul Wassmann, Thierry Monney, Christelle Ries Fecourt, Sunitha Gn, Vinu C A, Daniel Ayoub, Cian Stutz, Girish S Gudi & Stanislas Blein. (2019) Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development. mAbs 11:8, pages 1464-1478.
Read now
Read now
Adam R. Evans, Michael T. Capaldi, Geetha Goparaju, David Colter, Frank F. Shi, Sarah Aubert, Lian-Chao Li, Jingjie Mo, Michael J. Lewis, Ping Hu, Pedro Alfonso & Promod Mehndiratta. (2019) Using bispecific antibodies in forced degradation studies to analyze the structure–function relationships of symmetrically and asymmetrically modified antibodies. mAbs 11:6, pages 1101-1112.
Read now
Read now
Chen Chen, Tetsuya Wakabayashi, Masaru Muraoka, Feng Shu, Chia Wei Shan, Chong Chor Kun, Ching Tim Jang, Ishin Soehano, Yuichiro Shimizu, Tomoyuki Igawa & Jun-Ichi Nezu. (2019) Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency. mAbs 11:4, pages 632-638.
Read now
Read now
Dani Setiawan, Jeffrey Brender & Yang Zhang. (2018) Recent advances in automated protein design and its future challenges. Expert Opinion on Drug Discovery 13:7, pages 587-604.
Read now
Read now
Marie Godar, Hans de Haard, Christophe Blanchetot & Jacobus Rasser. (2018) Therapeutic bispecific antibody formats: a patent applications review (1994-2017). Expert Opinion on Therapeutic Patents 28:3, pages 251-276.
Read now
Read now
Nazzareno Dimasi, Ryan Fleming, Kris F. Sachsenmeier, Binyam Bezabeh, Carl Hay, Jincheng Wu, Erin Sult, Saravanan Rajan, Li Zhuang, Peter Cariuk, Andrew Buchanan, Michael A. Bowen, Herren Wu & Changshou Gao. (2017) Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain. mAbs 9:3, pages 438-454.
Read now
Read now
Ulrich Brinkmann & Roland E. Kontermann. (2017) The making of bispecific antibodies. mAbs 9:2, pages 182-212.
Read now
Read now
Yiyuan Yin, Guanghui Han, Jianhui Zhou, Michael Dillon, Luke McCarty, Lou Gavino, Diego Ellerman, Christoph Spiess, Wendy Sandoval & Paul J. Carter. (2016) Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometry. mAbs 8:8, pages 1467-1476.
Read now
Read now
Magdalena Malm, Fredrik Y. Frejd, Stefan Ståhl & John Löfblom. (2016) Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds. mAbs 8:7, pages 1195-1209.
Read now
Read now
Christian Klein, Wolfgang Schaefer & Jörg T. Regula. (2016) The use of CrossMAb technology for the generation of bi- and multispecific antibodies. mAbs 8:6, pages 1010-1020.
Read now
Read now
Bram G. Sengers, Sean McGinty, Fatma Z. Nouri, Maryam Argungu, Emma Hawkins, Aymen Hadji, Andrew Weber, Adam Taylor & Armin Sepp. (2016) Modeling bispecific monoclonal antibody interaction with two cell membrane targets indicates the importance of surface diffusion. mAbs 8:5, pages 905-915.
Read now
Read now
Markus Haberger, Michael Leiss, Anna-Katharina Heidenreich, Oxana Pester, Georg Hafenmair, Michaela Hook, Lea Bonnington, Harald Wegele, Markus Haindl, Dietmar Reusch & Patrick Bulau. (2016) Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry . mAbs 8:2, pages 331-339.
Read now
Read now
Wolfgang Schaefer, Hans R Völger, Stefan Lorenz, Sabine Imhof-Jung, Jörg T Regula, Christian Klein & Michael Mølhøj. (2016) Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry. mAbs 8:1, pages 49-55.
Read now
Read now
Markus Haberger, Anna-Katharina Heidenreich, Tilman Schlothauer, Michaela Hook, Jana Gassner, Katrin Bomans, Michelle Yegres, Adrian Zwick, Boris Zimmermann, Harald Wegele, Lea Bonnington, Dietmar Reusch & Patrick Bulau. (2015) Functional assessment of antibody oxidation by native mass spectrometry. mAbs 7:5, pages 891-900.
Read now
Read now
Yariv Mazor, Vaheh Oganesyan, Chunning Yang, Anna Hansen, Jihong Wang, Hongji Liu, Kris Sachsenmeier, Marcia Carlson, Dhanesh V Gadre, Martin Jack Borrok, Xiang-Qing Yu, William Dall’Acqua, Herren Wu & Partha Sarathi Chowdhury. (2015) Improving target cell specificity using a novel monovalent bispecific IgG design. mAbs 7:2, pages 377-389.
Read now
Read now
Yiren Xu, John Lee, Cuong Tran, Tyler H Heibeck, Willie D Wang, Junhao Yang, Ryan L Stafford, Alexander R Steiner, Aaron K Sato, Trevor J Hallam & Gang Yin. (2015) Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system . mAbs 7:1, pages 231-242.
Read now
Read now
Janice M Reichert, Alain Beck, Alexey A Lugovskoy, Thierry Wurch, Steven Coats & Randall J Brezski. (2014) 9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland. mAbs 6:2, pages 309-326.
Read now
Read now
Markus Haberger, Katrin Bomans, Katharina Diepold, Michaela Hook, Jana Gassner, Tilman Schlothauer, Adrian Zwick, Christian Spick, Jochen Felix Kepert, Brigitte Hienz, Michael Wiedmann, Hermann Beck, Philipp Metzger, Michael Mølhøj, Constanze Knoblich, Ulla Grauschopf, Dietmar Reusch & Patrick Bulau. (2014) Assessment of chemical modifications of sites in the CDRs of recombinant antibodies. mAbs 6:2, pages 327-339.
Read now
Read now
Ingo Schubert, Domenica Saul, Stefanie Nowecki, Andreas Mackensen, Georg H Fey & Fuat S Oduncu. (2014) A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells. mAbs 6:1, pages 286-296.
Read now
Read now
Michael J Gramer, Ewald TJ van den Bremer, Muriel D van Kampen, Amitava Kundu, Peter Kopfmann, Eric Etter, David Stinehelfer, Justin Long, Tom Lannom, Esther H Noordergraaf, Jolanda Gerritsen, Aran F Labrijn, Janine Schuurman, Patrick HC van Berkel & Paul WHI Parren. (2013) Production of stable bispecific IgG1 by controlled Fab-arm exchange. mAbs 5:6, pages 962-973.
Read now
Read now
Thomas Spreter Von Kreudenstein, Eric Escobar-Carbrera, Paula I. Lario, Igor D’Angelo, Karine Brault, John F Kelly, Yves Durocher, Jason Baardsnes, R. Jeremy Woods, Michael Hongwei Xie, Pierre-Alain Girod, Michael D. L. Suits, Martin J. Boulanger, David K. Y. Poon, Gordon Y. Ng & Surjit B. Dixit. (2013) Improving biophysical properties of a bispecific antibody scaffold to aid developability. mAbs 5:5, pages 646-654.
Read now
Read now
R. Jeremy Woods, Michael Hongwei Xie, Thomas Spreter Von Kreudenstein, Gordon Y. Ng & Surjit B. Dixit. (2013) LC-MS characterization and purity assessment of a prototype bispecific antibody. mAbs 5:5, pages 711-722.
Read now
Read now
Alain Beck, Paul J. Carter, Hans-Peter Gerber, Alexey A. Lugovskoy, Thierry Wurch, Jagath R. Junutula, Roland E Kontermann & Robert Mabry. (2013) 8th Annual European Antibody Congress 2012. mAbs 5:3, pages 339-357.
Read now
Read now
Futa Mimoto, Tomoyuki Igawa, Taichi Kuramochi, Hitoshi Katada, Shojiro Kadono, Takayuki Kamikawa, Meiri Shida-Kawazoe & Kunihiro Hattori. (2013) Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant. mAbs 5:2, pages 229-236.
Read now
Read now
Articles from other publishers (123)
Daniel Heinzelmann, Benjamin Lindner, Benjamin Renner, Simon Fischer, Patrick Schulz & Moritz Schmidt. (2023) Droplet digital PCR: A comprehensive tool for genetic analysis and prediction of bispecific antibody assembly during cell line development. New Biotechnology 78, pages 42-51.
Crossref
Crossref
Stefanie Wachter, Thibaut Angevin, Niket Bubna, Adelene Tan, Adam Cichy, David Brown, Leslie S. Wolfe, Ryan Sappington, Edward Lilla, Luke Berry, Dane Grismer, Christian Orth, Milan Blanusa, Sigma Mostafa, Hitto Kaufmann & Karin Felderer. (2023) Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics. Journal of Biotechnology 377, pages 13-22.
Crossref
Crossref
Monica L. Fernández-Quintero, Nancy D. Pomarici, Anna-Lena M. Fischer, Valentin J. Hoerschinger, Katharina B. Kroell, Jakob R. Riccabona, Anna S. Kamenik, Johannes R. Loeffler, James A. Ferguson, Hailee R. Perrett, Klaus R. Liedl, Julianna Han & Andrew B. Ward. (2023) Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines. Antibodies 12:4, pages 67.
Crossref
Crossref
Wanyuan Dong & Yifeng Li. (2023) Complementary methods for monitoring hole-hole homodimer associated with a WuXiBody-based asymmetric bispecific antibody. Protein Expression and Purification 210, pages 106316.
Crossref
Crossref
Mingkai Song, Hui Yang, Wanting Cao & Qingqing Liu. (2023) Separation of bispecific antibody related impurities with mixed-mode chromatography. Process Biochemistry 132, pages 110-120.
Crossref
Crossref
Jia Wang, Mengying Tian, Wanyuan Dong, Xudong Zhang & Yifeng Li. (2023) Protein A and CaptureSelect FcXP Affinity Resins Possess the Capability
of Differentiating Hole-hole Homodimer Isoforms. Protein & Peptide Letters 30:6, pages 498-505.
Crossref
Crossref
Rosendo C. Villafuerte-Vega, Henry W. Li, Thomas R. Slaney, Naresh Chennamsetty, Guodong Chen, Li Tao & Brandon T. Ruotolo. (2023) Ion Mobility-Mass Spectrometry and Collision-Induced Unfolding of Designed Bispecific Antibody Therapeutics. Analytical Chemistry 95:17, pages 6962-6970.
Crossref
Crossref
Aude I. Segaliny, Jayapriya Jayaraman, Xiaoming Chen, Jonathan Chong, Ryan Luxon, Audrey Fung, Qiwei Fu, Xianzhi Jiang, Rodrigo Rivera, Xiaoya Ma, Ci Ren, Jan Zimak, Per Niklas Hedde, Yonglei Shang, George Wu & Weian Zhao. (2023) A high throughput bispecific antibody discovery pipeline. Communications Biology 6:1.
Crossref
Crossref
Julia Harwardt, Stefania C. Carrara, Jan P. Bogen, Katrin Schoenfeld, Julius Grzeschik, Björn Hock & Harald Kolmar. (2023) Generation of a symmetrical trispecific NK cell engager based on a two-in-one antibody. Frontiers in Immunology 14.
Crossref
Crossref
Nancy D. Pomarici, Franz Waibl, Patrick K. Quoika, Alexander Bujotzek, Guy Georges, Monica L. Fernández-Quintero & Klaus R. Liedl. (2023) Structural mechanism of Fab domain dissociation as a measure of interface stability. Journal of Computer-Aided Molecular Design 37:4, pages 201-215.
Crossref
Crossref
Eirini Vamva, Stosh Ozog, Daniel P. Leaman, Rene Yu-Hong Cheng, Nicholas J. Irons, Andee Ott, Claire Stoffers, Iram Khan, Geraldine K.E. Goebrecht, Matthew R. Gardner, Michael Farzan, David J. Rawlings, Michael B. Zwick, Richard G. James & Bruce E. Torbett. (2023) A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin. Molecular Therapy - Methods & Clinical Development 28, pages 366-384.
Crossref
Crossref
Wolfgang Koehnlein, Annika Holzgreve, Klaus Schwendner, Romas Skudas & Florian Schelter. (2023) Purification of hydrophobic complex antibody formats using a moderately hydrophobic mixed mode cation exchange resin. Journal of Chromatography A 1687, pages 463696.
Crossref
Crossref
Serene W. Chen, Kong Meng Hoi, Farouq Bin Mahfut, Yuansheng Yang & Wei Zhang. (2022) Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography. Bioresources and Bioprocessing 9:1.
Crossref
Crossref
Yanling Wang, Haoran Qiu, Jeremy Minshull, Wilburt Tam, Xichan Hu, Carl Mieczkowski, Weibin Zheng, Chun Chu, Wenqiang Liu, Ferenc Boldog, Claes Gustafsson, Jean-Michel Gries & Wenfeng Xu. (2022) An innovative platform to improve asymmetric bispecific antibody assembly, purity, and expression level in stable pool and cell line development. Biochemical Engineering Journal 188, pages 108683.
Crossref
Crossref
Niels Bauer, Benedikt Oswald, Maximilian Eiche, Lisa Schiller, Emma Langguth, Christian Schantz, Andrea Osterlehner, Amy Shen, Shahram Misaghi, Julian Stingele & Simon Ausländer. (2022) An arrayed CRISPR screen reveals Myc depletion to increase productivity of difficult-to-express complex antibodies in CHO cells. Synthetic Biology 7:1.
Crossref
Crossref
Jingyue Kang, Tonglin Sun & Yan Zhang. (2022) Immunotherapeutic progress and application of bispecific antibody in cancer. Frontiers in Immunology 13.
Crossref
Crossref
Raffaella Iurlaro, Inja Waldhauer, Ester Planas-Rigol, Ester Bonfill-Teixidor, Alexandra Arias, Valeria Nicolini, Anne Freimoser-Grundschober, Isabel Cuartas, Alba Martínez-Moreno, Francisco Martínez-Ricarte, Esteban Cordero, Marta Cicuendez, Simona Casalino, Xavier Guardia-Reyes, Linda Fahrni, Thomas Pöschinger, Virginie Steinhart, Marine Richard, Stefanie Briner, Joerg Mueller, Franz Osl, Johannes Sam, Sara Colombetti, Marina Bacac, Christian Klein, Estela Pineda, Luis Reyes-Figueroa, Alberto Di Somma, Josep González, Paolo Nuciforo, Joan Carles, Maria Vieito, Josep Tabernero, Pablo Umaña & Joan Seoane. (2022) A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma. Molecular Cancer Therapeutics 21:10, pages 1499-1509.
Crossref
Crossref
Serene W. Chen, Kong Meng Hoi, Farouq Bin Mahfut, Yuansheng Yang & Wei Zhang. (2022) Effective flow-through polishing strategies for knob-into-hole bispecific antibodies. Bioresources and Bioprocessing 9:1.
Crossref
Crossref
Kamiyar Rezvani, Dominique WuDunn, Alan K. Hunter & Matthew T. Aspelund. (2022) Leveraging light chain binding avidity for control of mispaired byproducts during production of asymmetric bispecific antibodies. Journal of Chromatography A, pages 463533.
Crossref
Crossref
Ha Gyeong Shin, Ha Rim Yang, Aerin Yoon & Sukmook Lee. (2022) Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy. International Journal of Molecular Sciences 23:10, pages 5686.
Crossref
Crossref
Bastiaan L. Duivelshof, Alain Beck, Davy Guillarme & Valentina D'Atri. (2022) Bispecific antibody characterization by a combination of intact and site-specific/chain-specific LC/MS techniques. Talanta 236, pages 122836.
Crossref
Crossref
Aina Segués, Shuyu Huang, Alice Sijts, Pedro Berraondo & Dietmar M. Zaiss. 2022. New Antibody Formats. New Antibody Formats
45
70
.
Rebecca Epperly, Stephen Gottschalk & M. Paulina Velasquez. 2022. Gene and Cellular Immunotherapy for Cancer. Gene and Cellular Immunotherapy for Cancer
329
351
.
Bram Estes, Athena Sudom, Danyang Gong, Douglas A. Whittington, Vivian Li, Christopher Mohr, Danqing Li, Timothy P. Riley, Stone D.-H. Shi, Jun Zhang, Fernando Garces & Zhulun Wang. (2021) Next generation Fc scaffold for multispecific antibodies. iScience 24:12, pages 103447.
Crossref
Crossref
Farideh Ghalamfarsa, Seyyed Hossein Khatami, Omid Vakili, Mortaza Taheri-Anganeh, Amir Tajbakhsh, Amir Savardashtaki, Yousef Fazli, Leila Rezaei Uonaki, Zahra Shabaninejad, Ahmad Movahedpour & Ghasem Ghalamfarsa. (2021) Bispecific antibodies in colorectal cancer therapy: recent insights and emerging concepts. Immunotherapy 13:16, pages 1355-1367.
Crossref
Crossref
Cai Guo, Fuyi Chen, Qiang Xiao, Hannah B. Catterall, John H. Robinson, Zhulun Wang, Marissa Mock & René Hubert. (2021) Expression liabilities in a four‐chain bispecific molecule. Biotechnology and Bioengineering 118:10, pages 3744-3759.
Crossref
Crossref
Ravindra Kumar, Asya V. Grinberg, Huiming Li, Tzu-Hsing Kuo, Dianne Sako, Lavanya Krishnan, Katia Liharska, Jia Li, Rosa Grenha, Michelle C. Maguire, Steven D. Briscoe, R. Scott Pearsall, Brantley R. Herrin, Rajasekhar N. V. S. Suragani & Roselyne Castonguay. (2021) Functionally diverse heteromeric traps for ligands of the transforming growth factor-β superfamily. Scientific Reports 11:1.
Crossref
Crossref
Justin T Huckaby, Elisa Landoni, Timothy M Jacobs, Barbara Savoldo, Gianpietro Dotti & Samuel K Lai. (2021) Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells. Journal for ImmunoTherapy of Cancer 9:9, pages e002737.
Crossref
Crossref
Gabriele Antonarelli, Federica Giugliano, Chiara Corti, Matteo Repetto, Paolo Tarantino & Giuseppe Curigliano. (2021) Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies. Pharmaceuticals 14:9, pages 884.
Crossref
Crossref
S Jordan Kerns, Chaitra Belgur, Debora Petropolis, Marianne Kanellias, Riccardo Barrile, Johannes Sam, Tina Weinzierl, Tanja Fauti, Anne Freimoser-Grundschober, Jan Eckmann, Carina Hage, Martina Geiger, Patrick Ray Ng, William Tien-Street, Dimitris V Manatakis, Virginie Micallef, Regine Gerard, Michael Bscheider, Ekaterina Breous-Nystrom, Anneliese Schneider, Anna Maria Giusti, Cristina Bertinetti-Lapatki, Heather Shannon Grant, Adrian B Roth, Geraldine A Hamilton, Thomas Singer, Katia Karalis, Annie Moisan, Peter Bruenker, Christian Klein, Marina Bacac, Nikolce Gjorevski & Lauriane Cabon. (2021) Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies. eLife 10.
Crossref
Crossref
Markus Haberger, Anna-Katharina Heidenreich, Michaela Hook, Jürgen Fichtl, Rainer Lang, Florian Cymer, Mahdi Adibzadeh, Felix Kuhne, Harald Wegele, Dietmar Reusch, Lea Bonnington & Patrick Bulau. (2021) Multiattribute Monitoring of Antibody Charge Variants by Cation-Exchange Chromatography Coupled to Native Mass Spectrometry. Journal of the American Society for Mass Spectrometry 32:8, pages 2062-2071.
Crossref
Crossref
Tingwei Ren, Zhijun Tan, Vivekh Ehamparanathan, Angela Lewandowski, Sanchayita Ghose & Zheng Jian Li. (2021) Antibody disulfide bond reduction and recovery during biopharmaceutical process development—A review. Biotechnology and Bioengineering 118:8, pages 2829-2844.
Crossref
Crossref
Sowmya Rajendran, Sowmya Balasubramanian, Lynn Webster, Maggie Lee, Divya Vavilala, Nicolay Kulikov, Jessica Choi, Calvin Tang, Molly Hunter, Rebecca Wang, Harpreet Kaur, Surya Karunakaran, Varsha Sitaraman, Jeremy Minshull & Ferenc Boldog. (2021) Accelerating and de‐risking CMC development with transposon‐derived manufacturing cell lines. Biotechnology and Bioengineering 118:6, pages 2301-2311.
Crossref
Crossref
Jan P. Bogen, Stefania C. Carrara, David Fiebig, Julius Grzeschik, Björn Hock & Harald Kolmar. (2021) Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture. Frontiers in Immunology 12.
Crossref
Crossref
Serene W Chen & Wei Zhang. (2021) Current trends and challenges in the downstream purification of bispecific antibodies. Antibody Therapeutics 4:2, pages 73-88.
Crossref
Crossref
Takehisa Kitazawa, Koichiro Yoneyama & Tomoyuki Igawa. 2021. Successful Drug Discovery. Successful Drug Discovery
221
248
.
Yang Xiao, Peiran Chen, Cheng Luo, Ziyang Xu, Xue Li, Liqiong Liu & Liwen Zhao. (2021) Discovery of a novel anti PD-L1 X TIGIT bispecific antibody for the treatment of solid tumors.. Cancer Treatment and Research Communications 29, pages 100467.
Crossref
Crossref
Samvedna Saini & Yatender Kumar. 2021. Translational Biotechnology. Translational Biotechnology
233
266
.
Lucas Gutierrez, Nina S. Cauchon, Twinkle R. Christian, Michael J. Giffin & Michael J. Abernathy. (2020) The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations. Journal of Pharmaceutical Sciences 109:12, pages 3524-3534.
Crossref
Crossref
Shuyu Huang, Sander M. J. van Duijnhoven, Alice J. A. M. Sijts & Andrea van Elsas. (2020) Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy. Journal of Cancer Research and Clinical Oncology 146:12, pages 3111-3122.
Crossref
Crossref
Xiujuan Chen, Ying Wang, Ying Wang & Yifeng Li. (2020) Protein L chromatography: A useful tool for monitoring/separating homodimers during the purification of IgG-like asymmetric bispecific antibodies. Protein Expression and Purification 175, pages 105711.
Crossref
Crossref
Gaili Guo, Jinyu Han, Ying Wang & Yifeng Li. (2020) A potential downstream platform approach for WuXiBody-based IgG-like bispecific antibodies. Protein Expression and Purification 173, pages 105647.
Crossref
Crossref
Asako Harada, Akifumi Shioda, Tatsuya Ikuno, Yoshika Iwata, Hirotake Shiraiwa, Tetsuya Wakabayashi, Yuji Sano & Masayuki Mishima. (2020) In vitro toxicological support to establish specification limit for anti-CD3 monospecific impurity in a bispecific T cell engager drug, ERY974. Toxicology in Vitro 66, pages 104841.
Crossref
Crossref
Haitao Jiang, Wei Xu, Ren Liu, Balrina Gupta, Bruce Kilgore, Zhimei Du & Xiaoyu Yang. (2020) Characterization of Bispecific Antibody Production in Cell Cultures by Unique Mixed Mode Size Exclusion Chromatography. Analytical Chemistry 92:13, pages 9312-9321.
Crossref
Crossref
Martina Geiger, Kay-Gunnar Stubenrauch, Johannes Sam, Wolfgang F. Richter, Gregor Jordan, Jan Eckmann, Carina Hage, Valeria Nicolini, Anne Freimoser-Grundschober, Mirko Ritter, Matthias E. Lauer, Henning Stahlberg, Philippe Ringler, Jigar Patel, Eric Sullivan, Sandra Grau-Richards, Stefan Endres, Sebastian Kobold, Pablo Umaña, Peter Brünker & Christian Klein. (2020) Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody. Nature Communications 11:1.
Crossref
Crossref
Aerin Yoon, Shinai Lee, Sua Lee, Sojung Lim, Yong-Yea Park, Eunjung Song, Dong-Sik Kim, Kisu Kim & Yangmi Lim. (2020) A Novel T Cell-Engaging Bispecific Antibody for Treating Mesothelin-Positive Solid Tumors. Biomolecules 10:3, pages 399.
Crossref
Crossref
Sylvia Dietrich, Alec W. Gross, Stefan Becker, Björn Hock, Gerhard Stadlmayr, Florian Rüker & Gordana Wozniak-Knopp. (2020) Constant domain-exchanged Fab enables specific light chain pairing in heterodimeric bispecific SEED-antibodies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1868:1, pages 140250.
Crossref
Crossref
Yifeng Li, Ying Wang, Peter (Keqiang) Shen & Weichang Zhou. 2020. Approaches to the Purification, Analysis and Characterization of Antibody-Based Therapeutics. Approaches to the Purification, Analysis and Characterization of Antibody-Based Therapeutics
167
179
.
Weihua Hou, Qingyun Yuan, Xingxing Yuan, Yuxiong Wang, Wei Mo, Huijie Wang & Min Yu. (2018) A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer. Investigational New Drugs 37:5, pages 876-889.
Crossref
Crossref
Alina Schneider, Ingo H. Gorr, Vincent Larraillet, Timo Frensing & Oliver Popp. (2019) Reduction of IL‐2 fragmentation during manufacturing of a novel immunocytokine by DoE process optimization. Biotechnology and Bioengineering 116:10, pages 2503-2513.
Crossref
Crossref
Strohl & Naso. (2019) Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells. Antibodies 8:3, pages 41.
Crossref
Crossref
Justin T. Huckaby, Christina L. Parker, Tim M. Jacobs, Alison Schaefer, Daniel Wadsworth, Alexander Nguyen, Anting Wang, Jay Newby & Samuel K. Lai. (2019) Engineering Polymer‐Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus‐Covered Epithelium. Angewandte Chemie International Edition 58:17, pages 5604-5608.
Crossref
Crossref
Justin T. Huckaby, Christina L. Parker, Tim M. Jacobs, Alison Schaefer, Daniel Wadsworth, Alexander Nguyen, Anting Wang, Jay Newby & Samuel K. Lai. (2019) Engineering Polymer‐Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus‐Covered Epithelium. Angewandte Chemie 131:17, pages 5660-5664.
Crossref
Crossref
Michael E. Lindquist & Mark D. Hicar. (2019) B Cells and Antibodies in Kawasaki Disease. International Journal of Molecular Sciences 20:8, pages 1834.
Crossref
Crossref
Yifeng Li. (2019) A brief introduction of IgG-like bispecific antibody purification: Methods for removing product-related impurities. Protein Expression and Purification 155, pages 112-119.
Crossref
Crossref
Christian Klein, Wolfgang Schaefer, Joerg T. Regula, Charles Dumontet, Ulrich Brinkmann, Marina Bacac & Pablo Umaña. (2019) Engineering therapeutic bispecific antibodies using CrossMab technology. Methods 154, pages 21-31.
Crossref
Crossref
Hirotake Shiraiwa, Atsushi Narita, Mika Kamata-Sakurai, Takahiro Ishiguro, Yuji Sano, Naoka Hironiwa, Takashi Tsushima, Hiroaki Segawa, Toshiaki Tsunenari, Yosuke Ikeda, Yoko Kayukawa, Mizuho Noguchi, Tetsuya Wakabayashi, Akihisa Sakamoto, Hiroko Konishi, Taichi Kuramochi, Mika Endo, Kunihiro Hattori, Junichi Nezu & Tomoyuki Igawa. (2019) Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974. Methods 154, pages 10-20.
Crossref
Crossref
Lei Han, Huifang Zong, Yuexian Zhou, Zhidi Pan, Jie Chen, Kai Ding, Yueqing Xie, Hua Jiang, Baohong Zhang, Huili Lu, John Gilly & Jianwei Zhu. (2019) Naturally split intein Npu DnaE mediated rapid generation of bispecific IgG antibodies. Methods 154, pages 32-37.
Crossref
Crossref
Xiufeng Wu & Stephen J. Demarest. (2019) Building blocks for bispecific and trispecific antibodies. Methods 154, pages 3-9.
Crossref
Crossref
Laurent Peyrin-Biroulet, Stephen Demarest & Ajay Nirula. (2019) Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies. Autoimmunity Reviews 18:2, pages 123-128.
Crossref
Crossref
Dana Litvak-Greenfeld, Lilach Vaks, Stav Dror, Limor Nahary & Itai Benhar. 2019. Human Monoclonal Antibodies. Human Monoclonal Antibodies
431
454
.
Giovanni Magistrelli, Guillemette Pontini, Yves Poitevin, Pauline Malinge, Jérémie Bourguignon, Florence Gauye, Elise Fleury, Nicolas Plèche, Lydia Galissaires & Nicolas Fischer. (2018) Tuning Relative Polypeptide Expression to Optimize Assembly, Yield and Downstream Processing of Bispecific Antibodies. Antibodies 7:3, pages 29.
Crossref
Crossref
Simon Krah, Harald Kolmar, Stefan Becker & Stefan Zielonka. (2018) Engineering IgG-Like Bispecific Antibodies—An Overview. Antibodies 7:3, pages 28.
Crossref
Crossref
Lilach Vaks, Dana Litvak-Greenfeld, Stav Dror, Galia Matatov, Limor Nahary, Shiran Shapira, Rahely Hakim, Iris Alroy & Itai Benhar. (2018) Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide Bonds. Antibodies 7:3, pages 27.
Crossref
Crossref
Joerg Thomas Regula, Sabine Imhof-Jung, Michael Mølhøj, Joerg Benz, Andreas Ehler, Alexander Bujotzek, Wolfgang Schaefer & Christian Klein. (2018) Variable heavy–variable light domain and Fab-arm CrossMabs with charged residue exchanges to enforce correct light chain assembly. Protein Engineering, Design and Selection 31:7-8, pages 289-299.
Crossref
Crossref
Xiufeng Wu, Richard Yuan, Michael Bacica & Stephen J Demarest. (2018) Generation of orthogonal Fab-based trispecific antibody formats. Protein Engineering, Design and Selection 31:7-8, pages 249-256.
Crossref
Crossref
Andrew D. Tustian, Linus Laurin, Henrik Ihre, Travis Tran, Robert Stairs & Hanne Bak. (2018) Development of a novel affinity chromatography resin for platform purification of bispecific antibodies with modified protein a binding avidity. Biotechnology Progress 34:3, pages 650-658.
Crossref
Crossref
Peter Herbener, Kurt Schönfeld, Martin König, Matthias Germer, Jude M. Przyborski, Katrin Bernöster & Jörg Schüttrumpf. (2018) Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate. PLOS ONE 13:4, pages e0195823.
Crossref
Crossref
Ingrid Schmid, Lea Bonnington, Monika Gerl, Katrin Bomans, Anna Louisa Thaller, Katharina Wagner, Tilman Schlothauer, Roberto Falkenstein, Boris Zimmermann, Jürgen Kopitz, Max Hasmann, Frieder Bauss, Markus Haberger, Dietmar Reusch & Patrick Bulau. (2018) Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions. Communications Biology 1:1.
Crossref
Crossref
Petra Verdino, Shane Atwell & Stephen J Demarest. (2018) Emerging trends in bispecific antibody and scaffold protein therapeutics. Current Opinion in Chemical Engineering 19, pages 107-123.
Crossref
Crossref
William R. Strohl. (2017) Current progress in innovative engineered antibodies. Protein & Cell 9:1, pages 86-120.
Crossref
Crossref
Jijie Gu, Andrew McCluskey & Tariq Ghayur. 2017. Protein Therapeutics. Protein Therapeutics
229
270
.
Simon Krah, Carolin Sellmann, Laura Rhiel, Christian Schröter, Stephan Dickgiesser, Jan Beck, Stefan Zielonka, Lars Toleikis, Björn Hock, Harald Kolmar & Stefan Becker. (2017) Engineering bispecific antibodies with defined chain pairing. New Biotechnology 39, pages 167-173.
Crossref
Crossref
K. J. Froning, A. Leaver‐Fay, X. Wu, S. Phan, L. Gao, F. Huang, A. Pustilnik, M. Bacica, K. Houlihan, Q. Chai, J. R. Fitchett, J. Hendle, B. Kuhlman & S. J. Demarest. (2017) Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies. Protein Science 26:10, pages 2021-2038.
Crossref
Crossref
Séverine Fagète, Ledicia Botas-Perez, Irène Rossito-Borlat, Kenneth Adea, Franck Gueneau, Ulla Ravn, François Rousseau, Marie Kosco-Vilbois, Nicolas Fischer & Oliver Hartley. (2017) Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments. Protein Engineering, Design and Selection 30:9, pages 575-582.
Crossref
Crossref
Yi Feng Lee, Simon Kluters, Mirjam Hillmann, Thomas von Hirschheydt & Christian Frech. (2017) Modeling of bispecific antibody elution in mixed-mode cation-exchange chromatography. Journal of Separation Science 40:18, pages 3632-3645.
Crossref
Crossref
Lei Han, Junsheng Chen, Kai Ding, Huifang Zong, Yueqing Xie, Hua Jiang, Baohong Zhang, Huili Lu, Weihan Yin, John Gilly & Jianwei Zhu. (2017) Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system. Scientific Reports 7:1.
Crossref
Crossref
Hudie Wei, Haiyan Cai, Yuhao Jin, Pilin Wang, Qingqing Zhang, Yihui Lin, Weixiao Wang, Jinke Cheng, Naiyan Zeng, Ting Xu & Aiwu Zhou. (2017) Structural basis of a novel heterodimeric Fc for bispecific antibody production. Oncotarget 8:31, pages 51037-51049.
Crossref
Crossref
Darko Skegro, Cian Stutz, Romain Ollier, Emelie Svensson, Paul Wassmann, Florence Bourquin, Thierry Monney, Sunitha Gn & Stanislas Blein. (2017) Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies. Journal of Biological Chemistry 292:23, pages 9745-9759.
Crossref
Crossref
Yuki Ohmuro-Matsuyama, Keita Mori, Hirotsugu Hamada, Hiroshi Ueda & Hideki Yamaji. (2016) Electrostatic engineering of the interface between heavy and light chains promotes antibody Fab fragment production. Cytotechnology 69:3, pages 469-475.
Crossref
Crossref
Rabah Gahoual, Anna-Katharina Heidenreich, Govert W. Somsen, Patrick Bulau, Dietmar Reusch, Manfred Wuhrer & Markus Haberger. (2017) Detailed Characterization of Monoclonal Antibody Receptor Interaction Using Affinity Liquid Chromatography Hyphenated to Native Mass Spectrometry. Analytical Chemistry 89:10, pages 5404-5412.
Crossref
Crossref
Abhinav A. Shukla & Carnley L. Norman. 2017. Process Scale Purification of Antibodies. Process Scale Purification of Antibodies
559
594
.
S S Hoseini & N K Cheung. (2017) Acute myeloid leukemia targets for bispecific antibodies. Blood Cancer Journal 7:2, pages e522-e522.
Crossref
Crossref
Simon Krah, Christian Schröter, Carla Eller, Laura Rhiel, Nicolas Rasche, Jan Beck, Carolin Sellmann, Ralf Günther, Lars Toleikis, Björn Hock, Harald Kolmar & Stefan Becker. (2017) Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display. Protein Engineering Design and Selection.
Crossref
Crossref
Alain C. Tissot & Ulrich Brinkmann. 2017. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases
75
97
.
Luis Schachner, Guanghui Han, Michael Dillon, Jianhui Zhou, Luke McCarty, Diego Ellerman, Yiyuan Yin, Christoph Spiess, Jennie R. Lill, Paul J. Carter & Wendy Sandoval. (2016) Characterization of Chain Pairing Variants of Bispecific IgG Expressed in a Single Host Cell by High-Resolution Native and Denaturing Mass Spectrometry. Analytical Chemistry 88:24, pages 12122-12127.
Crossref
Crossref
James R. Kintzing, Maria V. Filsinger Interrante & Jennifer R. Cochran. (2016) Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment. Trends in Pharmacological Sciences 37:12, pages 993-1008.
Crossref
Crossref
Ji-Hee Ha, Jung-Eun Kim & Yong-Sung Kim. (2016) Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins. Frontiers in Immunology 7.
Crossref
Crossref
Ming Sun, Yue Li, Huiwen Zheng & Yiming Shao. (2016) Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies. Frontiers in Immunology 7.
Crossref
Crossref
Marie Godar, Virginia Morello, Ava Sadi, Anna Hultberg, Natalie De Jonge, Cristina Basilico, Valérie Hanssens, Michael Saunders, Bart N. Lambrecht, Mohamed El Khattabi, Hans de Haard, Paolo Michieli & Christophe Blanchetot. (2016) Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy. Scientific Reports 6:1.
Crossref
Crossref
Marina Bacac, Tanja Fauti, Johannes Sam, Sara Colombetti, Tina Weinzierl, Djamila Ouaret, Walter Bodmer, Steffi Lehmann, Thomas Hofer, Ralf J. Hosse, Ekkehard Moessner, Oliver Ast, Peter Bruenker, Sandra Grau-Richards, Teilo Schaller, Annette Seidl, Christian Gerdes, Mario Perro, Valeria Nicolini, Nathalie Steinhoff, Sherri Dudal, Sebastian Neumann, Thomas von Hirschheydt, Christiane Jaeger, Jose Saro, Vaios Karanikas, Christian Klein & Pablo Umaña. (2016) A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors. Clinical Cancer Research 22:13, pages 3286-3297.
Crossref
Crossref
Suparna Paul, Judy Connor, Tom Nesspor, Peter Haytko, Ken Boakye, Mark L. Chiu & Haiyan Jiang. (2016) An efficient process of generating bispecific antibodies via controlled Fab-arm exchange using culture supernatants. Protein Expression and Purification 121, pages 133-140.
Crossref
Crossref
Andrew Leaver-Fay, Karen J. Froning, Shane Atwell, Hector Aldaz, Anna Pustilnik, Frances Lu, Flora Huang, Richard Yuan, Saleema Hassanali, Aaron K. Chamberlain, Jonathan R. Fitchett, Stephen J. Demarest & Brian Kuhlman. (2016) Computationally Designed Bispecific Antibodies using Negative State Repertoires. Structure 24:4, pages 641-651.
Crossref
Crossref
Stefan Dengl, Claudio Sustmann & Ulrich Brinkmann. (2016) Engineered hapten‐binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload delivery. Immunological Reviews 270:1, pages 165-177.
Crossref
Crossref
Hye-Ji Choi, Ye-Jin Kim, Dong-Ki Choi & Yong-Sung Kim. (2015) Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening. PLOS ONE 10:12, pages e0145349.
Crossref
Crossref
Kathryn E. TillerPeter M. Tessier. (2015) Advances in Antibody Design. Annual Review of Biomedical Engineering 17:1, pages 191-216.
Crossref
Crossref
Klaus Mayer, Anna-Lena Baumann, Michael Grote, Stefan Seeber, Hubert Kettenberger, Sebastian Breuer, Tobias Killian, Wolfgang Schäfer & Ulrich Brinkmann. (2015) TriFabs—Trivalent IgG-Shaped Bispecific Antibody Derivatives: Design, Generation, Characterization and Application for Targeted Payload Delivery. International Journal of Molecular Sciences 16:11, pages 27497-27507.
Crossref
Crossref
Norbert SewaldNathan Higginson-Scott & Michael Ritchie. 2015. Optimizing Antibody-Drug Conjugates for Targeted Delivery of Therapeutics. Optimizing Antibody-Drug Conjugates for Targeted Delivery of Therapeutics
90
104
.
Frank D. Macchi, Feng Yang, Charlene Li, Chenchen Wang, Anh Nguyen Dang, Joseph C. Marhoul, Hui-min Zhang, Timothy Tully, Hongbin Liu, X. Christopher Yu & David A. Michels. (2015) Absolute Quantitation of Intact Recombinant Antibody Product Variants Using Mass Spectrometry. Analytical Chemistry 87:20, pages 10475-10482.
Crossref
Crossref
Simon Kluters, Mathias Hafner, Thomas von Hirschheydt & Christian Frech. (2015) Solvent modulated linear pH gradient elution for the purification of conventional and bispecific antibodies: Modeling and application. Journal of Chromatography A 1418, pages 119-129.
Crossref
Crossref
Roland E. Kontermann & Ulrich Brinkmann. (2015) Bispecific antibodies. Drug Discovery Today 20:7, pages 838-847.
Crossref
Crossref
Hye-Ji Choi, Seung-Hyeon Seok, Ye-Jin Kim, Min-Duk Seo & Yong-Sung Kim. (2015) Crystal structures of immunoglobulin Fc heterodimers reveal the molecular basis for heterodimer formation. Molecular Immunology 65:2, pages 377-383.
Crossref
Crossref
Zhi Liu, Esther C. Leng, Kannan Gunasekaran, Martin Pentony, Min Shen, Monique Howard, Janelle Stoops, Kathy Manchulenko, Vladimir Razinkov, Hua Liu, William Fanslow, Zhonghua Hu, Nancy Sun, Haruki Hasegawa, Rutilio Clark, Ian N. Foltz & Wei Yan. (2015) A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism. Journal of Biological Chemistry 290:12, pages 7535-7562.
Crossref
Crossref
Kenneth M. Prentice, Alison Wallace & Catherine M. Eakin. (2015) Inline Protein A Mass Spectrometry for Characterization of Monoclonal Antibodies. Analytical Chemistry 87:4, pages 2023-2028.
Crossref
Crossref
Nicolas Fischer, Greg Elson, Giovanni Magistrelli, Elie Dheilly, Nicolas Fouque, Amélie Laurendon, Franck Gueneau, Ulla Ravn, Jean-François Depoisier, Valery Moine, Sylvain Raimondi, Pauline Malinge, Laura Di Grazia, François Rousseau, Yves Poitevin, Sébastien Calloud, Pierre-Alexis Cayatte, Mathias Alcoz, Guillemette Pontini, Séverine Fagète, Lucile Broyer, Marie Corbier, Delphine Schrag, Gérard Didelot, Nicolas Bosson, Nessie Costes, Laura Cons, Vanessa Buatois, Zoe Johnson, Walter Ferlin, Krzysztof Masternak & Marie Kosco-Vilbois. (2015) Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG. Nature Communications 6:1.
Crossref
Crossref
Juan C. Almagro & Sreekumar Kodangattil. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
147
170
.
Alexey A. Lugovskoy & Melissa L. Geddie. 2015. Biobetters. Biobetters
203
220
.
Ulrich H. Weidle, Roland E. Kontermann & Ulrich Brinkmann. (2014) Tumor-Antigen–Binding Bispecific Antibodies for Cancer Treatment. Seminars in Oncology 41:5, pages 653-660.
Crossref
Crossref
Dafne Müller & Roland E. Kontermann. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
265
310
.
Christian Jost & Andreas Plückthun. (2014) Engineered proteins with desired specificity: DARPins, other alternative scaffolds and bispecific IgGs. Current Opinion in Structural Biology 27, pages 102-112.
Crossref
Crossref
Juergen M. Schanzer, Katharina Wartha, Rebecca Croasdale, Samuel Moser, Klaus-Peter Künkele, Carola Ries, Werner Scheuer, Harald Duerr, Sandra Pompiati, Jan Pollman, Jan Stracke, Wilma Lau, Stefan Ries, Ulrich Brinkmann, Christian Klein & Pablo Umana. (2014) A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties. Journal of Biological Chemistry 289:27, pages 18693-18706.
Crossref
Crossref
Haiming Luo, Hao Hong, Sarah P. Yang & Weibo Cai. (2014) Design and Applications of Bispecific Heterodimers: Molecular Imaging and beyond. Molecular Pharmaceutics 11:6, pages 1750-1761.
Crossref
Crossref
F. Mimoto, S. Kadono, H. Katada, T. Igawa, T. Kamikawa & K. Hattori. (2014) Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs. Molecular Immunology 58:1, pages 132-138.
Crossref
Crossref
Arvind Rajpal, Pavel Strop, Yik Andy Yeung, Javier Chaparro‐Riggers & Jaume Pons. 2014. Therapeutic Fc‐Fusion Proteins. Therapeutic Fc‐Fusion Proteins
1
44
.
Zhi Liu, Kannan Gunasekaran, Wei Wang, Vladimir Razinkov, Laura Sekirov, Esther Leng, Heather Sweet, Ian Foltz, Monique Howard, Anne-Marie Rousseau, Carl Kozlosky, William Fanslow & Wei Yan. (2014) Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies. Journal of Biological Chemistry 289:6, pages 3571-3590.
Crossref
Crossref
Steven M Lewis, Xiufeng Wu, Anna Pustilnik, Arlene Sereno, Flora Huang, Heather L Rick, Gurkan Guntas, Andrew Leaver-Fay, Eric M Smith, Carolyn Ho, Christophe Hansen-Estruch, Aaron K Chamberlain, Stephanie M Truhlar, Elaine M Conner, Shane Atwell, Brian Kuhlman & Stephen J Demarest. (2014) Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface. Nature Biotechnology 32:2, pages 191-198.
Crossref
Crossref
Thomas Spreter Von Kreudenstein, Paula I. Lario & Surjit B. Dixit. (2014) Protein engineering and the use of molecular modeling and simulation: The case of heterodimeric Fc engineering. Methods 65:1, pages 77-94.
Crossref
Crossref
Pierre Moretti, Darko Skegro, Romain Ollier, Paul Wassmann, Christel Aebischer, Thibault Laurent, Miriam Schmid-Printz, Roberto Giovannini, Stanislas Blein & Martin Bertschinger. (2013) BEAT® the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs. BMC Proceedings 7:S6.
Crossref
Crossref
Hye-Ji Choi, Ye-Jin Kim, Sangho Lee & Yong-Sung Kim. (2013) A Heterodimeric Fc-Based Bispecific Antibody Simultaneously Targeting VEGFR-2 and Met Exhibits Potent Antitumor Activity. Molecular Cancer Therapeutics 12:12, pages 2748-2759.
Crossref
Crossref
Sebastian Fenn, Christian B. Schiller, Julia J. Griese, Harald Duerr, Sabine Imhof-Jung, Christian Gassner, Joerg Moelleken, Joerg Thomas Regula, Wolfgang Schaefer, Markus Thomas, Christian Klein, Karl-Peter Hopfner & Hubert Kettenberger. (2013) Crystal Structure of an Anti-Ang2 CrossFab Demonstrates Complete Structural and Functional Integrity of the Variable Domain. PLoS ONE 8:4, pages e61953.
Crossref
Crossref
Zenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda, Yukiko Okuyama-Nishida, Chifumi Moriyama, Tetsuya Wakabayashi, Eriko Tanaka, Atsushi Muto, Tetsuo Kojima, Takehisa Kitazawa, Kazutaka Yoshihashi, Aya Harada, Miho Funaki, Kenta Haraya, Tatsuhiko Tachibana, Sachiyo Suzuki, Keiko Esaki, Yoshiaki Nabuchi & Kunihiro Hattori. (2013) Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity. PLoS ONE 8:2, pages e57479.
Crossref
Crossref
Alain Beck, Elsa Wagner-Rousset, Daniel Ayoub, Alain Van Dorsselaer & Sarah Sanglier-Cianférani. (2012) Characterization of Therapeutic Antibodies and Related Products. Analytical Chemistry 85:2, pages 715-736.
Crossref
Crossref
Kamiyar Rezvani, Dominique WuDunn, Alan K. Hunter & Matthew Aspelund. (2022) Leveraging Light Chain Binding Avidity for Control of Mispaired Byproducts During Production of Asymmetric Bispecific Antibodies. SSRN Electronic Journal.
Crossref
Crossref